Publication
Clinical Outcomes of Metastatic Renal Carcinoma Following Disease Progression to Programmed Death (PD)-1 or PD-L1 Inhibitors (IO)
A Meet-URO Group Real World Study (Meet-Uro 7)
Daniele Santini, Marco Stellato, Ugo De Giorgi, Francesco Pantano, Delia De Lisi, Chiara Casadei, Marco Maruzzo, Davide Bimbatti, Emanuele Naglieri, Sebastiano Buti, Melissa Bersanelli, Rocco De Vivo, Giuseppe Di Lorenzo, Andrea Sbrana, Elena Verzoni, Mariella Soraru’, Giuseppe Fornarini, Claudia Mucciarini, Francesco Grillone, Enrico Mini, Francesca Vignani, Laura Attademo, Sandro Pignata, Giuseppe Procopio
American Journal of Clinical Oncology, January 2021, Wolters Kluwer Health
DOI: 10.1097/coc.0000000000000791